We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
86 hedge funds and large institutions have $56.1M invested in Invesco Pharmaceuticals ETF in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 31 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
5% more capital invested
Capital invested by funds: $53.3M → $56.1M (+$2.8M)
4% more funds holding
Funds holding: 83 → 86 (+3)
1.6% more ownership
Funds ownership: 19.63% → 21.23% (+1.6%)
65% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 31
Holders
86
Holders Change
+3
Holders Change %
+3.61%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
11
Reduced
31
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.23M |
| 2 |
JGCM
Joseph Group Capital Management
Columbus,
Ohio
|
+$1.99M |
| 3 |
CRI
Commonwealth Retirement Investments
Richmond,
Virginia
|
+$1.46M |
| 4 |
PAM
Peak Asset Management
Louisville,
Colorado
|
+$476K |
| 5 |
JP Morgan Chase
New York
|
+$281K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.03M |
| 2 |
Goldman Sachs
New York
|
-$823K |
| 3 |
Vontobel Holding
Zurich,
Switzerland
|
-$543K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$468K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$378K |
